Ilyas S - Search Results

1

Ilyas S, DeMars CJ, Buttar NS. Ilyas S, et al. J Gastrointest Cancer. 2007;38(1):1-9. doi: 10.1007/s12029-007-9006-7. J Gastrointest Cancer. 2007. PMID: 19065715 Review.

2

Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.

Buttar NS, DeMars CJ, Lomberk G, Ilyas SI, Bonilla-Velez J, Achra S, Rashtak S, Wang KK, Fernandez-Zapico ME, Urrutia R. Buttar NS, et al. Among authors: ilyas si. J Biol Chem. 2010 Apr 9;285(15):11433-44. doi: 10.1074/jbc.M109.077065. Epub 2010 Feb 12. J Biol Chem. 2010. PMID: 20154088 Free PMC article.

3

Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.

Ilyas SI, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernández-Zapico ME, Buttar NS. Ilyas SI, et al. Cancer Res. 2010 Sep 1;70(17):6787-96. doi: 10.1158/0008-5472.CAN-10-0197. Epub 2010 Jul 20. Cancer Res. 2010. PMID: 20647328 Free PMC article.

4

Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krüppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases.

Lomberk G, Mathison AJ, Grzenda A, Seo S, DeMars CJ, Ilyas SI, Bonilla-Velez J, Calvo E, Fernandez-Zapico ME, Iovanna J, Buttar NS, Urrutia R. Lomberk G, et al. Among authors: ilyas si. J Biol Chem. 2012 Apr 13;287(16):13026-39. doi: 10.1074/jbc.M112.342634. Epub 2012 Feb 8. J Biol Chem. 2012. PMID: 22318730 Free PMC article.

5

The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?

Ilyas SI, Borad MJ. Ilyas SI, et al. J Gastrointest Oncol. 2016 Oct;7(5):789-796. doi: 10.21037/jgo.2016.08.12. J Gastrointest Oncol. 2016. PMID: 27747092 Free PMC article. Review.

6

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

Ilyas SI, Eaton JE, Gores GJ. Ilyas SI, et al. Clin Gastroenterol Hepatol. 2015 Nov;13(12):2152-65. doi: 10.1016/j.cgh.2015.05.035. Epub 2015 Jun 5. Clin Gastroenterol Hepatol. 2015. PMID: 26051390 Free PMC article. Review.

7

Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Wang J, Loeuillard E, Gores GJ, Ilyas SI. Wang J, et al. Expert Opin Ther Targets. 2021 Oct;25(10):835-845. doi: 10.1080/14728222.2021.2010046. Epub 2021 Dec 3. Expert Opin Ther Targets. 2021. PMID: 34806500 Free PMC article.

8

Emerging immunotherapy for HCC: A guide for hepatologists.

Foerster F, Gairing SJ, Ilyas SI, Galle PR. Foerster F, et al. Hepatology. 2022 Jun;75(6):1604-1626. doi: 10.1002/hep.32447. Epub 2022 Apr 7. Hepatology. 2022. PMID: 35253934 Free PMC article. Review.

9

Cholangiocarcinoma - novel biological insights and therapeutic strategies.

Ilyas SI, Affo S, Goyal L, Lamarca A, Sapisochin G, Yang JD, Gores GJ. Ilyas SI, et al. Nat Rev Clin Oncol. 2023 Jul;20(7):470-486. doi: 10.1038/s41571-023-00770-1. Epub 2023 May 15. Nat Rev Clin Oncol. 2023. PMID: 37188899 Free PMC article. Review.

10

Liver capsule: Cholangiocarcinoma (CCA).

Ilyas SI, Gores GJ. Ilyas SI, et al. Hepatology. 2016 Apr;63(4):1356. doi: 10.1002/hep.28401. Epub 2016 Feb 1. Hepatology. 2016. PMID: 26667406 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters